Dr. Catherine C. Smith, MD

Dr. Smith practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Smith's NPI, 1164471488, was assigned on May 6, 2006. Dr. Smith graduated from Duke University School Of Medicine in 2002. Dr. Smith holds California license A91953.

Dr. Smith's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Smith's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Smith to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smith practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Smith's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Smith is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Smith's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists chronic anemia, chronic leukemia and multiple myeloma among the conditions Dr. Smith treats.

CMS data shows 468 Medicare services from Dr. Smith across 4 procedure codes in 2024, for 107 Medicare patients. Medicare paid $35,355 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 107 Medicare patients who saw Dr. Smith in 2024. The largest group is 75 to 84, with 49 patients. 71% of them have high blood pressure, and 69% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Smith's median patient age at 68, with 46% women.

In 2024, Dr. Smith wrote 595 Medicare Part D claims for 69 patients. 58% of them were for generic drugs. CMS names the drug for 376 of them, across 18 drugs with 11 or more claims each, at $2,505,166 in total drug cost. In 2023, CMS named 267 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Smith for performance year 2024, reported as part of a group. Dr. Smith accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Smith as offering telehealth.

Dmand AI links 18 papers to Dr. Smith, published from 2002 to 2025. 2013 was the busiest year, with 2. The most frequent topics are Leukemia, Myeloid, Acute, Antineoplastic Agents and Disease Models, Animal. Dr. Smith's most frequent co-authors are Rebecca L. Olin, MD, Weiyun Z. Ai, MD and Jessica Kaplan Altman, MD.

Dmand AI links Dr. Smith to 2 clinical trials. Conditions studied include Leukemia, Myeloid, Acute and Leukemia, Myeloid.

CMS Open Payments shows 36 general payments to Dr. Smith from 9 drug and device companies from 2017 to 2025. Grants make up the largest share, 42% of the total. Genentech, Inc. paid the most, $42,184. It also lists 32 research payments totaling $9,006 from 2016 to 2022.

Dmand AI lists 1 award for Dr. Smith, most recently CMS Stage 1 EHR in 2013.

Dr. Smith graduated from Duke University School Of Medicine in 2002.

Dr. Smith is in network with 9 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.